title: Infliximab effective in steroid-dependent juvenile eosinophilic fasciitis.
authors.forename: N
authors.initials: N
authors.lastname: Tzaribachev
authors.forename: U
authors.initials: U
authors.lastname: Holzer
authors.forename: J
authors.initials: J
authors.lastname: Schedel
authors.forename: V
authors.initials: V
authors.lastname: Maier
authors.forename: R
authors.initials: R
authors.lastname: Klein
authors.forename: J
authors.initials: J
authors.lastname: Kuemmerle-Deschner
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001327:Autoimmune Diseases / Q000188:drug therapy*; D002648:Child; D004802:Eosinophilia / Q000188:drug therapy*; D005208:Fasciitis / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D008297:Male; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab